JPRN-UMIN000042010已完成未知
Registry of palmoplantar pustulosis (PPP) treatment patterns, disease burden and treatment outcomes in Japan - ProPuP
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.are receiving, or have received within the past 3 months, anti-inflammatory or analgesic systemic therapy such as oral corticosteroid, DMARDs, non-steroidal anti-inflammatory drugs, opioids, PDE4 inhibitor, or biologics for any other indication (e.g., psoriasis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, asthma) 2.have received an investigational drug (including investigational vaccines) or used an invasive investigational medical device within 3 months before the start of the study or the first data collection time point 3.are participating in an investigational study 4.are participating in another observational study for guselkumab (including a post-marketing surveillance study) 5.are unable to understand or sign a participation agreement/informed consent form 6.if the only treatment they have received for PPP has been antibiotics when the decision was made.
研究者
相似试验
已完成
3 期
A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar PustulosisPalmoplantaris PustulosisNCT00353119Innovaderm Research Inc.15
已完成
3 期
Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar PustulosisPalmoplantar Pustulosis (PPP)NCT04451720AbbVie119
Unknown
不适用
Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of PrevalenceGeneralized Pustular PsoriasisPalmoplantar PustulosisNCT04566471Peking University Third Hospital200
已完成
不适用
A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in JapanPalmoplantar PustulosisNCT04459507Janssen Pharmaceutical K.K.276
终止
4 期
Deucravacitinib for the Treatment of Palmoplantar PustulosisPalmoplantar PustulosisNCT05710185Brigham and Women's Hospital3